PGx Week 12 Practice Quiz: HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1

Test

(1)

Jugadas 44

Crear copia

Sobre esta actividad

Medications impacted by polymorphisms in HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1, and their associated toxicities.

Creada por

Sophia

Estados Unidos

Descarga la versión para jugar en papel

Top 10 resultados

#	Jugador	Acierto	tiempo
1	Sophia 6 de Noviembre de 2025	% 100	00:59
2	Austin 10 de Diciembre de 2025	% 100	01:08
3	Ahmad Tabel 10 de Diciembre de 2025	% 83	02:17

¿Quieres aparecer en el Top 10 de este juego? Inicia sesión para identificarte.

Crea tu propio juego gratis desde nuestro creador de juegos

Compite contra tus amigos para ver quien consigue la mejor puntuación en esta actividad

Crear reto


PGx Week 12 Practice Quiz: HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1Versión en línea Medications impacted by polymorphisms in HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1, and their associated toxicities. por Sophia 1 Which of the following medications are impacted by HLA-B15:02 polymorphisms? Select all that apply. Choose one or more answers a Abacavir b Allopurinol c Carbamazepine d Phenytoin 2 Polymorphisms in which of the following alleles can impact how a patient tolerates carbamazepine? Select all that apply. Choose one or more answers a HLA-B15:02 b HLA-A31:01 c HLA-B57:01 d HLA-B58:01 3 A 35-year-old patient is being evaluated for initiation of abacavir as part of antiretroviral therapy. HLA genotyping results are as follows: HLA-A: 31:01 / Y HLA-B: 15:02 / X, 57:01 / *57:01 What is the most appropriate recommendation regarding abacavir therapy for this patient? a Start abacavir as planned; the patient can safely receive it. b Start abacavir at a 25% increased dose to ensure proper therapeutic effect. c Do not start abacavir; choose an alternative agent due to risk of hypersensitivity reaction. d Start abacavir at a 50% reduced dose to minimize risk of hypersensitivity reaction. 4 Which of the following anesthetics is safe to use in a patient who tests positive for inherited autosomal dominant pattern for both RYR1 and CACNA1S ("MHS causative" variants)? a rocuronium b succinylcholine c halothane d methoxyflurane 5 Which of the following medications do NOT have to be avoided in patients with G6PD deficiency? a dapsone b nitrofurantoin c rasburicase d gentamicin 6 Which of the following statements regarding MT-RNR1 and aminoglycosides is FALSE? a nephrotoxicity is a known side effect of aminoglycosides b aminoglycoside-induced hearing loss is permanent c aminoglycoside-induced hearing loss occurs gradually after repeated aminoglycoside doses d variants in MT-RNR1 predispose individuals to aminoglycoside-induced hearing loss

PGx Week 12 Practice Quiz: HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1Versión en línea

Medications impacted by polymorphisms in HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1, and their associated toxicities.

por Sophia

Which of the following medications are impacted by HLA-B*15:02 polymorphisms? Select all that apply.

Choose one or more answers

Abacavir

Allopurinol

Carbamazepine

Phenytoin

Polymorphisms in which of the following alleles can impact how a patient tolerates carbamazepine? Select all that apply.

Choose one or more answers

HLA-B*15:02

HLA-A*31:01

HLA-B*57:01

HLA-B*58:01

A 35-year-old patient is being evaluated for initiation of abacavir as part of antiretroviral therapy. HLA genotyping results are as follows: HLA-A: 31:01 / Y HLA-B: 15:02 / X, 57:01 / 57:01 What is the most appropriate recommendation regarding abacavir therapy for this patient?

Start abacavir as planned; the patient can safely receive it.

Start abacavir at a 25% increased dose to ensure proper therapeutic effect.

Do not start abacavir; choose an alternative agent due to risk of hypersensitivity reaction.

Start abacavir at a 50% reduced dose to minimize risk of hypersensitivity reaction.

Which of the following anesthetics is safe to use in a patient who tests positive for inherited autosomal dominant pattern for both RYR1 and CACNA1S ("MHS causative" variants)?

rocuronium

succinylcholine

halothane

methoxyflurane

Which of the following medications do NOT have to be avoided in patients with G6PD deficiency?

dapsone

nitrofurantoin

rasburicase

gentamicin

Which of the following statements regarding MT-RNR1 and aminoglycosides is FALSE?

nephrotoxicity is a known side effect of aminoglycosides

aminoglycoside-induced hearing loss is permanent

aminoglycoside-induced hearing loss occurs gradually after repeated aminoglycoside doses

variants in MT-RNR1 predispose individuals to aminoglycoside-induced hearing loss

Puedes integrar el juego en un LMS compatible con LTI 1.1 o LTI 1.3 como Canvas, Moodle, o Blackboard. De esta manera podrás guardar las puntuaciones automáticamente en el libro de calificaciones de esa plataforma.

PGx Week 12 Practice Quiz: HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1

Test

Sobre esta actividad

Creada por

Descarga la versión para jugar en papel

Top juegos

Test

cuanto sabes de Futbol

Test

Verbos irregulares en Inglés

Test

Brawl stars preguntas

Test

Cultura general española

Test

Tipos de sintagmas (II)

PGx Week 12 Practice Quiz: HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1Versión en línea

por Sophia

Which of the following medications are impacted by HLA-B*15:02 polymorphisms? Select all that apply.

Choose one or more answers

Polymorphisms in which of the following alleles can impact how a patient tolerates carbamazepine? Select all that apply.

Choose one or more answers

A 35-year-old patient is being evaluated for initiation of abacavir as part of antiretroviral therapy. HLA genotyping results are as follows: HLA-A: 31:01 / Y HLA-B: 15:02 / X, 57:01 / 57:01 What is the most appropriate recommendation regarding abacavir therapy for this patient?

Which of the following anesthetics is safe to use in a patient who tests positive for inherited autosomal dominant pattern for both RYR1 and CACNA1S ("MHS causative" variants)?

Which of the following medications do NOT have to be avoided in patients with G6PD deficiency?

Which of the following statements regarding MT-RNR1 and aminoglycosides is FALSE?

		%
	Anónimo	%
		%
		%

PGx Week 12 Practice Quiz: HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1

Test

Sobre esta actividad

Creada por

Descarga la versión para jugar en papel

Top juegos

Test

cuanto sabes de Futbol

Test

Verbos irregulares en Inglés

Test

Brawl stars preguntas

Test

Cultura general española

Test

Tipos de sintagmas (II)

PGx Week 12 Practice Quiz: HLA-B, RYR1, CACNA1S, G6PD, and mtRNR1Versión en línea

por Sophia

Which of the following medications are impacted by HLA-B*15:02 polymorphisms? Select all that apply.

Polymorphisms in which of the following alleles can impact how a patient tolerates carbamazepine? Select all that apply.

A 35-year-old patient is being evaluated for initiation of abacavir as part of antiretroviral therapy. HLA genotyping results are as follows: HLA-A: *31:01 / *Y HLA-B: *15:02 / *X, *57:01 / *57:01 What is the most appropriate recommendation regarding abacavir therapy for this patient?

Which of the following anesthetics is safe to use in a patient who tests positive for inherited autosomal dominant pattern for both RYR1 and CACNA1S ("MHS causative" variants)?

Which of the following medications do NOT have to be avoided in patients with G6PD deficiency?

Which of the following statements regarding MT-RNR1 and aminoglycosides is FALSE?

A 35-year-old patient is being evaluated for initiation of abacavir as part of antiretroviral therapy. HLA genotyping results are as follows: HLA-A: 31:01 / Y HLA-B: 15:02 / X, 57:01 / 57:01 What is the most appropriate recommendation regarding abacavir therapy for this patient?